Michael V. O'Shaughnessy

Overview

Best Publications

• Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy

  Robert S. Hogg;Katherine V. Heath;Benita Yip;Kevin J. P. Craib

  1114
  Citations

• Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy

  Robert S. Hogg;Benita Yip;Keith J. Chan;Evan Wood

  1019
  Citations

• Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

  Steffanie A. Strathdee;David M. Patrick;Sue L. Currie;Peter G. A. Cornelisse

  820
  Citations

• Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients

  Hélène C F Côté;Zabrina L Brumme;Kevin J P Craib;Christopher S Alexander

  730
  Citations

• Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users

  Steffanie A. Strathdee;Anita Palepu;Peter G. A. Cornelisse;Benita Yip

  605
  Citations

• Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

  Robert S Hogg;Katherine Heath;David Bangsberg;Benita Yip

  540
  Citations

• Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.

  Evan Wood;Robert S. Hogg;Benita Yip;P. Richard Harrigan

  486
  Citations

• Decline in deaths from AIDS due to new antiretrovirals.

  Robert S Hogg;Michael V O'Shaughnessy;Nada Gataric;Benita Yip

  471
  Citations

• Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.

  Mark W Tyndall;Sue Currie;Patricia Spittal;Kathy Li

  459
  Citations

• Adherence to triple therapy and viral load response.

  Sophie Low-Beer;Benita Yip;Michael V. O'Shaughnessy;Robert S. Hogg

  385
  Citations

• Hospital utilization and costs in a cohort of injection drug users

  Anita Palepu;Mark W. Tyndall;Hector Leon;Jennifer Muller

  334
  Citations

• Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database.

  K V Heath;R S Hogg;K J Chan;M Harris

  316
  Citations

• Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection

  David M. Patrick;Mark W. Tyndall;Peter G.A. Cornelisse;Kathy Li

  295
  Citations

• Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver

  Patricia M. Spittal;Kevin J.P. Craib;Evan Wood;Nancy Laliberté

  285
  Citations

• Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?

  Evan Wood;Mark W. Tyndall;Patricia M. Spittal;Kathy Li

  281
  Citations

• Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users

  Evan Wood;Julio S.G. Montaner;Benita Yip;Mark W. Tyndall

  279
  Citations

• Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver

  Kevin J.P. Craib;Patricia M. Spittal;Evan Wood;Nancy Laliberte

  277
  Citations

• Nontuberculous Mycobacterial Immune Reconstitution Syndrome in HIV-Infected Patients: Spectrum of Disease and Long-Term Follow-Up

  Peter Phillips;Simon Bonner;Nada Gataric;Tony Bai

  267
  Citations

• Determinants of sexual risk-taking among young HIV-negative gay and bisexual men.

  Steffanie A. Strathdee;Robert S. Hogg;Stephen L. Martindale;Peter G. A. Cornelisse

  258
  Citations

• The impact of adherence on CD4 cell count responses among HIV-infected patients.

  Evan Wood;Robert S. Hogg;Benita Yip;P. Richard Harrigan

  231
  Citations